Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02320513 · ClinicalTrials.gov registry record

A Comparison of Physical Activity Levels With and Without Feedback Via Fitbit® Flex™ in Hemodialysis Patients

A clinical trial of End Stage Renal Disease, sponsored by Renal Research Institute.

Completed
Registry status
33
Enrollment target
1
Study location

NCT02320513 is a study of End Stage Renal Disease that has completed, run by Renal Research Institute. The registered enrollment target is 33 participants, below the 833-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02320513, a study of End Stage Renal Disease, has completed, sponsored by Renal Research Institute.

COMPLETED
Registry status
33 participants
Enrollment target
1
Study location

Study Summary

This is a pilot study intended to gather data in order to inform future studies about the role of feedback as an incentive for increasing levels of physical activity which could improve health in hemodialysis patients.

Conditions Studied

End Stage Renal Disease

Interventions

  • OTHER Wearing activty monitoring device (Fitbit Flex)
  • DEVICE Fitbit Flex

Study Locations (1)

New York

  • Avantua Upper East Side Dialysis Center - New York

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2014-10
Est. Completion 2015-06

Sponsor

Renal Research Institute

14 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02320513

The ClinicalTrials.gov registry entry for NCT02320513 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 833-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (96% lower). The listed sponsor is Renal Research Institute, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with End Stage Renal Disease appearing as the primary indexed condition, and to 2 interventions - of which Wearing activty monitoring device (Fitbit Flex) is the first listed.

NCT02320513 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02320513 about?

NCT02320513 is a clinical study titled "A Comparison of Physical Activity Levels With and Without Feedback Via Fitbit® Flex™ in Hemodialysis Patients". This is a pilot study intended to gather data in order to inform future studies about the role of feedback as an incentive for increasing levels of physical activity which could improve health in hemodialysis patients.

What is the current status of trial NCT02320513?

This trial is currently completed. The enrollment target is 33 participants. The study started on 2014-10. Estimated completion is 2015-06.

What conditions does trial NCT02320513 study?

This clinical trial studies the following conditions: End Stage Renal Disease.

What interventions are being tested in trial NCT02320513?

The interventions under investigation include: Wearing activty monitoring device (Fitbit Flex) (OTHER), Fitbit Flex (DEVICE).

Who is sponsoring clinical trial NCT02320513?

This trial is sponsored by Renal Research Institute, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02320513 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for End Stage Renal Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

End Stage Renal Disease

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.